Revvity, Inc.
Revvity, Inc.
RVTY
Valuace
0
Růst
23
Zdraví
81
Cena
$ 92.19
Dnes
--2.83 (-2.45%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
10.9B
Obrat
3B
Zisk
0B
Aktiva
12B
Dluh
3B
ROE
0%
ROA
0%
PE
40
PS
3
Cena 1R
81-128
⌀ Cena
94.30
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
02-02-2026
Nadcházející dividenda
17-04-2026

Profil

Společnost Revvity, Inc. poskytuje produkty, služby a řešení pro trhy diagnostiky, věd o živé přírodě a aplikovaných služeb po celém světě. Působí ve dvou segmentech: Discovery & Analytical Solutions a Diagnostics. Segment Discovery & Analytical Solutions poskytuje nástroje, činidla, informatiku, software, předplatné, detekční a zobrazovací technologie, které vědcům umožňují zlepšit průlomové výsledky výzkumu na trhu výzkumu v oblasti věd o živé přírodě, jakož i smluvní výzkum a laboratorní služby. Poskytuje také analytické technologie, řešení a služby pro své zákazníky, aby pochopili charakteristiku zdraví různých aspektů, včetně ovzduší, vody a půdy. Kromě toho tento segment nabízí řešení pro zemědělce a výrobce potravin a analytické nástroje pro průmyslový trh, který zahrnuje chemický, polovodičový a elektronický průmysl, energetiku, mazadla, petrochemický a polymerový průmysl. Segment diagnostiky poskytuje nástroje, činidla, testovací platformy a softwarové produkty pro včasnou detekci genetických poruch, jako je těhotenství a rané dětství, stejně jako testování infekčních nemocí na diagnostickém trhu. Jeho produkty se používají k testování a screeningu genetických abnormalit, poruch a nemocí, včetně downsyndromu, hypotyreózy, svalové dystrofie, neplodnosti a různých metabolických stavů. Tento segment také vyvíjí technologie, které umožňují a podporují genomické pracovní postupy pomocí proteinových vázaných receptorů a sekvenování DNA nové generace pro aplikace v onkologii, imunodiagnostice a objevování léčiv. Slouží farmaceutickým a biotechnologickým společnostem, laboratořím, akademickým a výzkumným institucím, orgánům veřejného zdravotnictví, soukromým zdravotnickým organizacím, lékařům a vládním agenturám. Společnost byla dříve známá jako PerkinElmer, Inc. a v dubnu 2023 změnila své jméno na Revvity, Inc. Revvity, Inc. byla založena v roce 1937 a sídlí ve Walthamu v Massachusetts.
Sektor
Healthcare
Odvětví
Medical - Diagnostics & Research
Počet zaměstnanců
11000
Založení
1965-07-06
Adresa
940 Winter Street
CEO
Prahlad R. Singh

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues2,856.12,856.12,755.02,750.63,311.85,067.23,782.72,883.72,778.02,257.02,115.52,262.42,237.22,166.22,115.21,921.31,704.3
Cost of Revenues1,423.51,340.01,432.41,210.91,322.02,215.91,672.91,487.61,437.11,184.01,102.21,237.91,232.61,189.31,152.01,070.7945.7
Gross Profit1,432.51,516.11,322.71,539.71,989.82,851.32,109.91,396.11,340.91,073.01,013.41,024.51,004.6977.0963.2850.6758.6
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues772.1698.9720.3664.8729.4684.0691.7649.9695.9670.7
Cost of Revenues433.9324.3327.7337.5369.7299.2306.2294.9402.0298.2
Gross Profit338.1374.6392.6327.2359.7384.8385.5355.0293.9372.5
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0216.6221.6275.0205.4189.3194.0139.4124.3125.9121.1133.0132.6115.895.4
Selling General & Admin Expenses0.00.00.01,022.61,025.51,227.5917.9815.3811.9616.2600.9598.8659.3585.9632.7628.6490.7
Depreciation & Amortization405.3302.3427.8431.8455.8413.1232.0217.3179.7153.8102.1121.5125.3154.9126.9129.3109.0
Total Operating Expenses1,060.21,159.4912.11,239.11,247.11,502.51,123.31,004.71,005.9755.6725.2724.8780.5718.9765.4744.4586.1
Operating Income372.4356.6410.5300.6742.71,332.4978.6362.0323.9304.8283.1286.1210.7217.4195.789.7153.6
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.049.653.0
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0167.1250.2
Depreciation & Amortization103.1102.1102.897.4105.0107.7107.2107.8105.6108.3
Total Operating Expenses226.4292.7301.8239.3227.4282.2284.0280.9216.7303.3
Operating Income111.781.990.888.0132.3102.6101.574.177.269.2
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income31.131.173.272.13.62.21.01.51.12.60.70.70.70.70.71.90.8
Interest Expense92.292.296.398.8104.0102.149.763.667.043.941.538.036.349.945.824.815.9
Other Expense-104.1-88.4-94.4-117.6-90.9-52.5-72.2-124.8-66.2-8.1-39.0-42.1-41.1-64.1-145.1-26.88.4
IBT268.3268.3316.1183.0651.81,279.9906.4237.1257.7296.7244.1244.0169.6153.350.662.9162.0
Income Tax Expense25.825.833.13.5129.2347.6178.39.420.2139.828.431.38.4-12.2-17.962.826.1
Net Income241.7241.7295.8693.1579.2932.2727.9227.6237.9156.9234.3212.4157.8164.869.90.2135.9
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income5.86.98.310.19.822.820.520.118.423.5
Interest Expense23.522.822.923.022.824.424.724.424.625.5
Other Expense-20.2-26.2-22.1-35.6-37.7-2.2-14.9-39.6-45.8-18.6
IBT91.655.768.752.494.6100.486.734.531.450.6
Income Tax Expense-6.88.513.410.76.27.014.15.9-32.218.1
Net Income98.446.755.241.495.094.079.127.778.69.5
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$5.56$4.51$8.12$6.52$2.06$2.15$1.43$2.14$1.89$1.40$1.49$0.61$0.00$1.16
EPS Diluted$0.00$0.00$0.00$5.55$4.50$8.08$6.49$2.04$2.13$1.42$2.12$1.87$1.39$1.47$0.61$0.00$1.15
Shares Outstanding113.2113.2122.8124.7126.2116.2111.5110.8110.6109.9109.5112.5112.6112.3113.7113.0117.1
Diluted Shares Outstanding113.2113.2122.8124.8126.4116.7112.1111.5111.5110.9110.3113.3113.7113.5114.9113.9118.0
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.83$0.08
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.83$0.08
Shares Outstanding113.2117.7117.5120.1121.8122.8123.4123.4123.4124.0
Diluted Shares Outstanding113.2117.7117.5120.2121.6123.0123.5123.5123.4124.2
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents1,248.11,163.4913.2454.4618.3402.0191.9163.1202.1359.3237.9174.8173.2171.4142.3420.1
Short Term Investments706.10.0689.90.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments1,954.21,163.41,603.1454.4618.3402.0191.9163.1202.1359.3237.9174.8173.2171.4142.3420.1
Accounts Receivable597.4632.4632.8612.81,023.81,205.1725.2632.7552.3425.6439.0470.6470.0457.0414.0356.8
Inventory401.4367.6428.1405.5624.7514.6356.9338.3351.7246.8288.0285.5261.0247.7240.8207.3
Other Current Assets205.6186.2337.1122.3174.0167.2100.5100.594.099.268.2137.2140.595.669.4100.9
Total Current Assets3,158.72,349.63,001.13,297.82,440.82,288.91,374.51,234.61,200.11,189.91,033.21,068.01,044.8971.8866.71,085.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents931.4991.81,137.61,163.41,229.81,248.1998.1914.41,136.71,331.9
Short Term Investments0.00.00.00.00.0706.1697.3689.9293.0739.1
Total Cash & ST Investments931.4991.81,137.61,163.41,229.81,954.21,695.41,604.31,429.72,071.0
Accounts Receivable680.3661.1617.4632.4602.1597.4589.0632.8644.6626.9
Inventory379.9388.5381.3367.6404.6401.4414.0428.1435.7436.8
Other Current Assets152.2194.7181.6186.2211.9205.6360.9337.1403.3388.6
Total Current Assets2,143.82,236.22,317.92,349.62,448.43,158.73,059.33,001.12,913.23,523.3
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment646.9649.9664.7671.3753.4575.5485.5318.6298.1145.5167.0176.2185.4210.5174.6161.8
Goodwill6,497.06,463.66,533.66,481.87,416.63,447.13,111.22,952.62,982.22,248.02,279.22,284.12,143.12,122.82,093.61,504.8
Intangible Assets2,825.52,640.93,022.33,377.24,063.11,365.71,283.31,199.71,366.9420.2490.8490.3460.4529.9661.6424.2
Long-Term Investments0.0124.982.80.00.00.00.00.00.01.71.61.61.31.11.11.4
Other Long-Term Assets296.8163.5252.0298.8341.7333.0290.0270.0244.3271.4167.4114.4111.665.741.132.1
Total Long-Term Assets10,266.210,042.910,563.610,829.012,574.85,721.45,170.04,740.84,891.53,086.83,106.03,066.52,901.92,930.02,972.02,124.3
Total Assets13,424.812,392.513,564.714,126.915,015.68,010.36,544.65,975.56,091.64,276.74,139.24,134.53,946.73,901.83,838.73,209.4
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment668.2676.2660.4649.9667.2646.9652.7664.7645.9658.0
Goodwill6,600.66,615.06,511.56,463.66,558.76,497.06,503.96,533.66,470.16,518.4
Intangible Assets2,425.92,514.42,571.42,640.92,763.22,825.52,919.13,022.33,085.33,197.2
Long-Term Investments0.00.00.0124.90.00.00.0114.70.00.0
Other Long-Term Assets300.4321.1299.6163.5332.2296.8297.6220.1307.0321.6
Total Long-Term Assets9,995.210,126.610,042.810,042.910,321.310,266.210,373.410,563.610,508.310,695.2
Total Assets12,139.012,362.812,360.712,392.512,769.713,424.813,432.713,564.713,421.514,218.5
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable174.9167.5204.1272.8355.5327.3235.9220.9222.1168.0152.7174.0167.2168.9178.9161.0
Short-Term Debt711.423.8754.8470.94.2380.910.015.8215.51.21.11.12.61.80.02.3
Other Current Liabilities503.7321.6267.9687.2567.1600.2358.7380.8347.9271.2244.5255.4268.3256.1423.3351.9
Current Liabilities1,390.0653.11,450.51,566.51,230.31,702.2768.8772.6945.4603.4561.5599.4602.8581.1602.2515.2
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable175.8178.2178.1167.5176.4174.9183.5204.1188.3235.7
Short-Term Debt583.80.20.223.81.0711.4711.4754.8727.5478.9
Other Current Liabilities463.1493.4469.9321.6510.5503.7479.2267.9532.0652.2
Current Liabilities1,222.7671.8648.2653.1687.91,390.01,374.21,450.51,447.81,366.8
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt3,162.63,302.03,310.54,093.35,165.11,798.12,210.41,875.61,790.61,045.31,011.81,051.9932.1938.8944.9424.0
Capital Leases123.1151.5165.7170.0185.4188.4146.41.50.00.00.00.00.00.00.00.0
Def. Tax Liability878.80.00.01,109.21,480.50.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities5,554.54,725.65,691.96,734.07,885.34,274.83,730.73,390.53,588.42,123.12,028.72,092.41,954.61,962.01,997.51,283.6
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt2,785.23,374.63,325.13,302.03,314.13,285.73,292.23,310.53,286.44,027.9
Capital Leases154.5160.3156.7151.5128.4123.1127.2132.7133.9144.2
Def. Tax Liability0.00.00.00.00.00.00.00.00.0953.8
Total Liabilities4,763.14,806.64,723.64,725.64,848.05,554.55,586.25,691.95,727.36,348.6
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock123.4120.6123.4126.3126.2112.1111.1110.6110.4109.6112.0112.5112.6115.0113.2115.7
Retained Earnings5,673.35,845.25,609.24,951.04,417.23,507.32,812.02,602.12,380.52,118.71,991.41,810.51,684.41,548.61,510.71,639.6
Comprehensive Income-341.9-396.1-276.7-447.5-162.7-32.0-199.6-176.5-46.5-100.9-46.024.877.666.654.1-53.5
Total Common Equity7,870.37,666.97,872.77,392.97,130.23,735.52,813.82,585.02,503.22,153.62,110.42,042.11,992.11,939.81,841.21,925.8
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.0116.3119.4120.6122.1123.4123.5123.4123.3124.3
Retained Earnings5,963.85,925.15,879.25,845.25,759.15,673.35,626.65,609.25,539.45,538.5
Comprehensive Income-179.8-157.5-316.5-396.1-231.9-341.9-325.4-276.7-379.2-305.0
Total Common Equity7,375.97,556.27,637.17,666.97,921.77,870.37,846.57,872.77,694.37,870.0
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt3,997.13,325.84,065.34,564.25,169.32,179.12,220.41,891.52,006.11,046.41,012.91,053.0934.7940.6944.9426.3
Book Value7,870.37,666.97,872.77,392.97,130.23,735.52,813.82,585.02,503.22,153.62,110.42,042.11,992.11,939.81,841.21,925.8
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value7,375.97,556.27,637.17,666.97,921.77,870.37,846.57,872.77,694.37,870.0
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income197.3241.2283.1179.5579.2932.2727.9227.8237.5156.9215.7212.7161.2165.568.40.2135.9
Depreciation & Amortization428.9405.3427.8431.8427.0358.0246.5214.0180.6105.0100.0112.0116.7128.5126.9110.989.2
Stock-Based Compensation40.122.837.841.451.532.829.131.528.825.417.217.714.514.121.015.512.4
Change Working Capital-95.3-96.8-18.3-391.3-382.1104.4-115.8-173.3-148.2-37.7-35.0-84.2-105.1-177.6-206.1-67.9-62.9
Change In Accounts Receivable29.4-101.0-16.0-9.066.1155.4-423.9-100.6-94.5-36.6-19.06.8-17.0-14.4-44.6-24.8-38.1
Change In Accounts Payable-50.27.3-26.0-76.4-43.80.862.87.48.934.330.7-16.18.1-1.8-7.94.027.8
Change In Inventories29.914.845.1-14.1-48.62.4-122.5-9.6-30.2-17.96.8-28.7-24.6-13.9-8.2-2.2-22.6
Other Non-cash Items502.570.78.2-72.6111.619.932.4116.646.79.859.640.8135.392.5206.186.515.2
Cash from Operations469.30.00.091.3679.81,410.8892.2363.5311.0288.5350.6287.1281.6158.6152.2224.9164.3
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income98.446.755.241.788.493.472.628.763.632.5
Depreciation & Amortization103.1102.1102.897.4105.0107.7107.3107.8105.6108.3
Stock-Based Compensation-4.19.110.17.75.110.510.511.77.210.7
Change Working Capital1.1-15.7-48.9-13.360.6-48.5-11.7-18.782.8-147.6
Change In Accounts Receivable-59.4-19.7-40.018.1-49.35.1-9.037.221.9-20.7
Change In Accounts Payable7.1-3.0-5.68.9-1.2-1.8-4.7-18.29.0-36.2
Change In Inventories2.36.911.1-5.518.39.610.07.220.7-8.1
Other Non-cash Items46.3-3.515.0-5.4-84.8-15.2-20.218.161.213.4
Cash from Operations0.00.00.00.00.00.00.00.0196.6-33.5
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-86.3-73.5-86.6-81.4-85.6-99.9-77.5-81.3-93.3-39.1-31.7-29.6-29.1-39.0-42.4-30.6-33.6
Acquisitions-1.20.00.0-2.17.0-3,989.8-407.2-399.9-59.7-1,526.1-50.9-72.0-271.5-15.7-40.9-914.0-150.4
Investments-396.4-0.4-6.6-1,227.9-47.2-23.1-20.1-6.4-7.0-10.80.00.00.00.00.00.00.0
Sales of Investment-100.00.0712.5550.085.699.977.581.393.336.50.00.00.00.00.00.00.0
Other Investing Activities707.00.00.02,074.9-7.00.10.30.00.1290.0-18.20.84.753.53.034.8479.2
Cash from Investing123.40.00.01,313.5-132.9-4,112.8-504.5-487.6-159.9-1,249.4-100.8-100.9-295.9-1.2-80.3-909.9295.1
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-20.2-18.5-18.9-16.0-24.5-22.3-22.0-17.8-24.1-22.4
Acquisitions0.00.00.00.20.00.00.00.00.0-1.2
Investments-0.40.00.00.0-2.30.0-4.0-0.3-390.7-1.0
Sales of Investment0.00.00.00.00.0712.50.00.0-550.0450.0
Other Investing Activities0.00.00.00.00.00.00.00.0550.09.5
Cash from Investing0.00.00.00.00.00.00.00.0-414.8434.9
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-478.80.00.0-517.5-799.2-1,912.4-902.2-2,237.7-1,292.4-238.8-903.6-486.1-356.0-699.1-435.9-765.3-509.1
Debt Issued-30.93,325.8-739.518.5194.14,902.7860.82,566.71,177.81,198.5937.1446.0474.2693.3431.51,284.0935.3
Issuance of Common Stock7.20.00.00.014.10.00.00.00.00.00.00.00.00.00.023.729.0
Repurchase of Common Stock-145.9-820.8-369.6-388.9-80.6-73.1-6.9-6.3-57.4-3.8-151.8-76.4-65.5-127.4-2.1-110.0-72.8
Dividends Paid-34.60.00.0-35.0-35.3-32.4-31.2-31.1-31.0-30.8-30.8-31.6-31.6-31.6-31.9-31.8-33.0
Other Financing Activities-15.40.00.0-5.8239.24,959.5737.52,425.21,201.61,055.7971.2486.9484.1704.0425.71,280.6367.4
Cash from Financing-667.20.00.0-947.1-661.82,941.7-202.9150.1-179.2782.2-115.0-107.130.9-154.2-44.2397.2-218.4
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.0-467.1
Debt Issued3,369.0-5.949.5-0.410.7-682.0-6.5-28.818.5-25.8
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock-168.3-205.0-293.9-153.6-185.2-154.1-19.6-10.8-4.9-110.7
Dividends Paid0.00.00.00.00.00.00.00.0-8.6-8.7
Other Financing Activities0.00.00.00.00.00.00.00.0-6.10.5
Cash from Financing0.00.00.00.00.00.00.00.0-19.6-586.0
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-82.6-244.6250.1443.6-148.6216.7210.725.6-36.1-157.1121.363.11.61.829.1-277.7240.4
Closing Cash Balance1,248.1919.91,164.5914.4470.7619.3402.6191.9166.3202.1359.3237.9174.8173.2171.4142.3420.1
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-12.7-60.4-145.7-25.8-66.4-18.6250.085.1-222.3-195.4
Closing Cash Balance919.9932.6993.01,138.71,164.51,230.81,249.4999.5914.41,138.0
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow383.0508.3541.79.9594.21,310.9814.7282.1217.8249.4318.9257.5252.5119.6109.8194.3130.6
Real Free Cash Flow342.9485.4503.8-31.5542.71,278.1785.5250.6189.0223.9301.8239.7238.1105.588.7178.8118.2
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow163.1120.1115.5112.2149.8125.6136.6129.7172.5-55.8
Real Free Cash Flow167.2111.0105.3104.4144.7115.0126.1118.0165.3-66.5
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E40.3-50.563
P/S3.43.257.8
P/B1.32.629.8
P/FCF19.937.3549.4
Market cap$10.9$12.7
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %27 %0 %
Debt to Income1394 %-2181.6 %0 %
Debt to Free cash flow690.4 %16.6 %0 %
Interest expense percentage24.8 %18.3 %2.9 %
Current ratio1.8 1.9 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE3.3 %7.5 %0 %
ROA2 %3.7 %0 %
CapEx to Revenue2.6 %2.1 %0 %
RaD to Revenue0 %6 %0 %
ROEM259,641.0 3846.9

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin50.2 %48.7 %47.8 %
Operating margin13 %13.2 %28 %
Net margin8.5 %9 %19.8 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0.5 %0 %
Dividend payout percentage0 %62.1 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding113.2 mil 115.7 mil
Employee count11.0 tis 11.0 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader